Detroit 2026 Hematology and Oncology Practice Symposium

08:30 AM - 08:50 AM

Management of EGFR mutated non small cell lung cancer – Angel Qin, MD

08:50 AM - 09:30 AM

Case-Based Panel Discussion – Angel Qin, MD; Raed M Alnajjar, MD; Linda Albusoul, MD; Adam Forman, MD; Khaled Adil, MD; Radhika Gutta, DO

10:00 AM - 10:20 AM

What is the current landscape of immunotherapy in colorectal cancer? – Ibrahim Halil Sahin, MD

10:20 AM - 11:00 AM

Case-Based Panel Discussion – Rupen Shah, MD, MD; Ibrahim Halil Sahin, MD; Parag Parikh, MD; philip agop philip, MD; Kimberly Boldig, DO

11:00 AM - 11:20 AM

Approach to Managing RCC (Clear and Non-Clear Cell) – Emerson Lim, MD

11:20 AM - 12:00 PM

Case-Based Panel Discussion – Udit Singhal, MD; Emerson Lim, MD; Clara Hwang, MD; Maha Bayya, MD

01:00 PM - 01:45 PM

The Current and Future Landscape of Antibody Drug Conjugates in Solid Oncology – Paolo Tarantino, MD

01:45 PM - 02:00 PM

Q & A

02:00 PM - 02:20 PM

Novel strategies for HER2 Positive Breast Cancer – Marian Girgis, MD

02:20 PM - 03:00 PM

Case-Based Panel Discussion – Theresa Schwartz, MD; Shouq Kherallah, MD; Frank Vicini, MD; Mohammad Muhsin Chisti, MD; MacKenzie Mayo, MD

03:15 PM - 03:35 PM

Smoldering Myeloma: to treat or not to treat – Jeffrey A Zonder, MD

03:35 PM - 04:15 PM

Case-Based Panel Discussion – Shatha Farhan, MD; Jawad Sheqwara, MD; Jeffrey A Zonder, MD; Ali Gabali, PhD; Vijendra Singh, MD; Asmita Shukla, MD